26 results found.

End Stage Renal Disease Clinical Trial using Dialysis session of at least 4.25 hours

University of Pennsylvania - Recruiting 18 years or older.
- Time to Reduce Mortality in End-Stage Renal Disease (TiME) Trial.
Dialysis session of at least 4.25 hours

Obstructive Sleep Apnea, or End Stage Renal Disease Clinical Trial using No Sleep Apnea; Sleep Apnea - untreated; Sleep Apnea - treated

Centre Hospitalier Universitaire Vaudois - Recruiting 18 years or older.
- Prognostic Impact of Sleep Apnea on Cardiovascular Morbidity and Mortality, in End Stage Renal Disease Patients.
No Sleep Apnea; Sleep Apnea - untreated; Sleep Apnea - treated

End Stage Renal Disease, Kidney Disease, or Protein Energy Wastin Clinical Trial using PINTA 745; Placebo

Pinta Biotherapeutics - Recruiting 18 years to 85 years.
- A Randomized, Double-blind, Pilot Study of PINTA 745, an Anti-myostatin Peptibody, in Patients With End Stage Renal Disease Who Require Maintenance Hemodialysis and Have Protein Energy Wasting.
PINTA 745; Placebo

End Stage Renal Disease Clinical Trial using duplex Doppler ultrasonography

Yonsei University - Recruiting 20 years to 60 years.
- .
duplex Doppler ultrasonography

End-stage Kidney Disease, or End-stage Renal Disease Clinical Trial using Optiflow

Bioconnect Systems, Inc - Recruiting 18 years to 75 years.
- The 'OPEN' Study Optiflow PatEncy and MaturatioN.
Optiflow

End-stage Renal Disease, or Kidney Failure, Chronic Clinical Trial using HAVG graft implantation

Humacyte, Inc. - Recruiting 18 years to 75 years.
- A Pilot Study for Evaluation of the Safety and Efficacy of Humacyte's Human Acellular Vascular Graft for Use as a Vascular Prosthesis for Hemodialysis Access in Patients With End-Stage Renal Disease.
HAVG graft implantation

Relapsed Multiple Myeloma, or End-stage Renal Disease Clinical Trial using Carfilzomib

Onyx Pharmaceuticals - Recruiting 18 years or older.
- An Open-Label, Single Arm, Phase 1 Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Relapsed Multiple Myeloma and End-stage Renal Disease.
Carfilzomib

End Stage Renal Disease Clinical Trial using Kidney Transplant

University of Kansas - Recruiting 30 years to 70 years.
- Cognitive Impairment and Imaging Correlates in End Stage Renal Disease.
Kidney Transplant

Uremic Pruritus Clinical Trial using Nalfurafine hydrochloride 2.5æg; Nalfurafine hydrochloride 5æg; Nalfurafine hydrochloride 10æg; Placebo

Mitsubishi Tanabe Pharma Corporation - Recruiting 18 years or older.
- A Phase 2, Randomized, Double-blind, Placebo-controlled, Fixed-dose, Parallel-group, Multicenter, Efficacy, and Safety Study of MT-9938 for Treatment of Uremic Pruritus in Subjects With End-stage Renal Disease Receiving Hemodialysis.
Nalfurafine hydrochloride 2.5æg; Nalfurafine hydrochloride 5æg; Nalfurafine hydrochloride 10æg; Placebo

Cancer, Congestive Heart Failure (CHF), Chronic Obstructive Pulmo Clinical Trial using Life Completion; Attention Control

Department of Veterans Affairs - Recruiting 18 years or older.
- Outlook: An Intervention to Improve Quality of Life in Serious Illness Study.
Life Completion; Attention Control

End Stage Renal Disease Clinical Trial using Treatment modification

The Rogosin Institute - Recruiting N/A or older.
- Treatment Modification and Symptom Burden in High-Risk Dialysis Patients.
Treatment modification

Chronic Kidney Disease, or End-Stage Renal Disease Clinical Trial using Medication Information Transfer Intervention; Usual care for hospital discharge

Providence Medical Research Center - Recruiting 21 years or older.
- Medication Intervention in Transitional Care to Optimize Outcomes & Costs in CKD & ESRD.
Medication Information Transfer Intervention; Usual care for hospital discharge

Kidney Failure, Chronic, or End Stage Renal Disease, Requiring Di Clinical Trial using NxStage System One

NxStage Medical - Recruiting 18 years or older.
- Comparison of Nocturnal Hemodialysis (NHD) and Short Daily Hemodialysis (DHD) With the NxStager System OneT.
NxStage System One

End-stage Renal Disease Clinical Trial

Kyungpook National University - Recruiting 18 years or older.
- A Prospective, Multicenter, Observational Study to Evaluate the Impact of Peritoneal Dialysis Compared With Hemodialysis on Iron Metabolism and Hepcidin.

Chronic Kidney Disease (CKD), or End-Stage Renal Disease (ESRD) Clinical Trial

Los Angeles Biomedical Research Institute - Recruiting 18 years to 85 years.
- Malnutrition, Diet and Racial Disparities in Chronic Kidney Disease (CKD) - A Prospective Data Collection Study.

End Stage Renal Disease Clinical Trial using extended treatment time; Standard treatment time

Imperial College London - Recruiting 18 years or older.
- Feasibility and Physiological and Nutritional Effects of Extended Treatment Duration in Patients With End-stage Renal Disease on Haemodialysis.
extended treatment time; Standard treatment time

Hemodialysis, End-stage Renal Disease, Hypertension, or Intradial Clinical Trial

University of Texas Southwestern Medical Center - Recruiting 18 years to 85 years.
- Mechanisms and Treatment of Intradialytic Hypertension - Sodium.

End Stage Renal Disease, or Myocardial Microvascular Disease Clinical Trial using Invasive FFR + CFR measurements are performed during coronary angiography using a pressure guide wire

Hospices Civils de Lyon - Recruiting 18 years or older.
- Detection and Outcomes of Myocardial Microvascular Disease in Patients With End Stage Renal Disease.
Invasive FFR + CFR measurements are performed during coronary angiography using a pressure guide wire

Hypertension, or Hemodialysis Clinical Trial using BP education and BP self-regulation; Supportive Educative Nursing Intervention

Wayne State University - Recruiting 18 years or older.
- Improving Blood Pressure Control in End-Stage Renal Disease Through a Supportive-Educative Nursing Intervention.
BP education and BP self-regulation; Supportive Educative Nursing Intervention

End-Stage Renal Disease Clinical Trial using 6 L dialysate; 8 L dialysate

Shanghai Jiao Tong University School of Medicine - Recruiting 18 years to 80 years.
- Effect of Different Dialysis Dosage on Prognosis in Maintenance Peritoneal Dialysis Patients - A Prospective, Randomized, Controlled, Multi-Center Clinical Study.
6 L dialysate; 8 L dialysate

Insulin Resistance, Diabetes, or End Stage Renal Disease Clinical Trial

IRCCS Policlinico S. Matteo - Recruiting 18 years to 70 years.
- Insulin Resistance And End Stage Renal Disease: The Role Of Retinol Binding Protein 4.

End Stage Renal Disease, Hypoalbuminemia, or Malnutrition Clinical Trial using Protein Food Bar Intelligent Indulgence

Satellite Healthcare - Recruiting 18 years or older.
- Impact of Providing High Protein Bar to Dialysis Patients With Low Serum Albumin.
Protein Food Bar Intelligent Indulgence

Hypotension, End Stage Renal Disease, or Intra Dialytic Hypotensi Clinical Trial using MTR107

Wolfson Medical Center - Recruiting 20 years to 75 years.
- A Phase II, Randomized Double Blind Placebo-Controlled, Dose Escalating Study to Determine Pharmacokinetic and Pharmacodynamic Effects of MTR107 in End-Stage Renal Disease (ESRD) Patients.
MTR107

End-Stage Renal Disease Clinical Trial using Cool Dialysate

National Institute of Nursing Research (NINR) - Recruiting 21 years to 75 years.
- The Effects of Hemodialysis on the Sleep/Wake Cycle.
Cool Dialysate